Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 306

1.
2.

Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?

Gómez-Puerta JA, Martín H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamashta MA.

Medicine (Baltimore). 2005 Jul;84(4):225-30.

3.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
4.

Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.

Lefèvre G, Lambert M, Bacri JL, Dubucquoi S, Quemeneur T, Caron C, Launay D, Houfflin-Debarge V, Hachulla E, Kyndt X, Subtil D, Hatron PY.

Lupus. 2011 Jul;20(8):861-5. doi: 10.1177/0961203310397080. Epub 2011 May 5.

PMID:
21546412
5.

Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.

Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G, Kiss E.

Clin Rev Allergy Immunol. 2007 Apr;32(2):131-7.

PMID:
17916982
6.

Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity.

Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, Tona F, Iliceto S, Pengo V.

Thromb Haemost. 2006 Sep;96(3):337-41.

PMID:
16953276
9.

Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.

Musial J, Swadzba J, Motyl A, Iwaniec T.

J Rheumatol. 2003 Apr;30(4):723-30.

PMID:
12672190
10.

Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.

Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M.

Haematologica. 2000 Jun;85(6):632-7.

11.

Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome.

Fujieda Y, Atsumi T, Amengual O, Odani T, Otomo K, Kato M, Oku K, Kon Y, Horita T, Yasuda S, Koike T.

Lupus. 2012 Dec;21(14):1506-14. doi: 10.1177/0961203312458469. Epub 2012 Aug 30.

PMID:
22936124
12.

Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.

Parkpian V, Verasertniyom O, Vanichapuntu M, Totemchokchyakarn K, Nantiruj K, Pisitkul P, Angchaisuksiri P, Archararit N, Rachakom B, Ayurachai K, Janwityanujit S.

Clin Rheumatol. 2007 Oct;26(10):1663-70. Epub 2007 Mar 2.

PMID:
17332980
13.

Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?

Harris EN, Pierangeli SS.

Semin Thromb Hemost. 2008 Apr;34(3):219-26. doi: 10.1055/s-0028-1082265. Review.

PMID:
18720301
14.

Antiphospholipid syndrome and recurrent thrombosis in children.

Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G.

Arthritis Rheum. 2006 Dec 15;55(6):850-5.

15.

Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.

Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.

Arthritis Rheum. 2004 Aug;50(8):2569-79.

16.

Assessment of the 2006 revised antiphospholipid syndrome classification criteria.

Kaul M, Erkan D, Sammaritano L, Lockshin MD.

Ann Rheum Dis. 2007 Jul;66(7):927-30. Epub 2007 Mar 2.

17.

Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.

Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.

J Rheumatol. 2009 Jun;36(6):1195-9. doi: 10.3899/jrheum.081194. Epub 2009 May 15.

PMID:
19447935
18.

Clinical study and follow-up of 100 patients with the antiphospholipid syndrome.

Muñoz-Rodriguez FJ, Font J, Cervera R, Reverter JC, Tàssies D, Espinosa G, López-Soto A, Carmona F, Balasch J, Ordinas A, Ingelmo M.

Semin Arthritis Rheum. 1999 Dec;29(3):182-90.

PMID:
10622682
19.

Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.

Carmo-Pereira S, Bertolaccini ML, Escudero-Contreras A, Khamashta MA, Hughes GR.

Ann Rheum Dis. 2003 Jun;62(6):540-3.

20.

Validation of the Sapporo criteria for antiphospholipid syndrome.

Lockshin MD, Sammaritano LR, Schwartzman S.

Arthritis Rheum. 2000 Feb;43(2):440-3.

Supplemental Content

Support Center